Clinical deterioration creates signals. Reliable rescue requires a system that carries them through action and closure.
PRISMqd is an early-stage clinical-safety operating architecture being developed to help hospitals preserve, interpret, escalate, act on, reassess, validate, measure, and learn from decision-critical safety signals.
Failure-to-rescue is the anchor use case. The larger objective is a more coherent operating model for clinical-safety intelligence, rescue readiness, and accountable learning.
Read the Clinical Safety Signal Infrastructure BriefCurrent stage: documented architecture, published frameworks, inspectable prototypes, and paid design-partnership development. PRISMqd has not yet established clinical, operational, or economic outcomes.
A signal is not useful merely because it was recorded.
Clinical deterioration crosses people, roles, systems, and time. Recognition may occur without shared interpretation. Escalation may occur without ownership. Action may occur without reassessment. Reporting may occur without closure or organizational learning.
PRISMqd organizes that sequence as one operating problem: how does decision-critical information retain meaning, authority, and accountability from first recognition through validated resolution?
This is an architectural proposition to be tested with health-system partners. It is not a claim that one model explains every adverse event.
One sequence. Nine decision stages. Clear ownership.
Recognize
Detection, recognition, and interpretation establish what the signal may mean.
Mobilize
Prioritization, communication, and escalation connect concern with authority.
Close
Action, reassessment, and validation make response and residual risk visible.
The Continuity Risk Framework gives leaders a common structure for examining where information changes, stalls, loses authority, or fails to reach verified closure. It is intended to support local assessment, workflow design, governance, measurement, and learning—not to replace clinical judgment or local policy.
Begin with the workflow before adding software.
The first enterprise pathway is a manual-first rescue-reliability implementation system. A partner organization defines one bounded workflow, establishes local decision rights, selects process and balancing measures, tests the operating model, and reviews what the evidence supports before considering broader implementation or software enablement.
Assess
Document the current workflow, roles, policies, measures, and constraints.
Plan
Define local adaptations, governance, measures, responsibilities, and stop rules.
Test
Run a contained, reversible test under the organization’s clinical authority.
Evaluate
Review fidelity, burden, equity, unintended effects, and what the evidence supports.
Decide
Continue, revise, expand, or stop.
Built far enough to inspect. Early enough to test honestly.
Available for review
- Published clinical-safety and governance frameworks with persistent records
- Defined rescue-readiness implementation architecture
- Product specifications and workflow models
- Inspectable interface artifacts and working browser prototypes
- A U.S. provisional patent application filed for the PRISMqd architecture
Not yet established
- Clinical effectiveness
- Operational effectiveness
- Economic impact or return on investment
- Enterprise deployment or repeatable adoption
- Regulatory classification or clearance for future software capabilities
Different tools for different points in the safety system.
Rescue Readiness Implementation System
A licensed, adaptable implementation system for examining rescue workflows, governance, measurement, training, and organizational learning. Software is not required to begin testing the workflow.
SafeChart
A clinician-controlled professional documentation concept designed to help preserve contemporaneous information about unsafe conditions, escalation attempts, responses, and follow-up. It is separate from the patient record, does not replace EHR documentation, and is not legal advice or a clinical-decision tool.
LineMap
A product concept for structured IV-access mapping, infusion-to-lumen planning, compatibility constraints, and handoff continuity. The current artifact demonstrates interaction and workflow logic. It is not a production clinical system and has not established clinical outcomes.
View the prototype contextCOMPASS
A proposed clinician-reviewed assessment and longitudinal tracking framework. COMPASS is not a validated diagnostic instrument and must not be used to diagnose, exclude, or direct treatment.
Review the frameworkTest one consequential workflow with clear boundaries.
PRISMqd is seeking a health-system partner willing to examine one defined rescue-readiness workflow through a paid, 90-day design partnership.
The partnership is designed to answer practical questions before scale: Does the architecture fit the local workflow? Can responsibilities and measures be made explicit? What implementation burden does the model create? Which assumptions fail under real operating conditions? What evidence would justify continuation?
The organization retains local clinical authority. Scope, data access, privacy, security, measures, decision rights, and stop rules are established in writing before work begins. The engagement does not guarantee improved outcomes, savings, compliance, or future licensing.
Read the briefDesigned from frontline experience and systems-level inquiry.
Jennifer Torrez, BSN, RN, is the founder and CEO of PRISMqd. Her work draws on more than 20 years in healthcare, including critical care, rapid response, high-acuity operations, technology adoption, research translation, and systems analysis.
She created PRISMqd to translate recurring clinical-safety problems into inspectable architectures, decision models, implementation tools, and product concepts that can be examined rather than accepted on authority.
Review Jennifer Torrez’s selected work$2M pre-seed: build the operating model, generate the evidence, and earn the right to scale.
The round is intended to advance controlled enterprise design partnerships, evidence generation, product finalization, clinical and regulatory review, human-factors validation, and technical work tied to validated workflows.
Review the investor overview